Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Rodriguez Poncelas, Antonio ^a,b,e   Coll De Tuero, Gabriel ^a,b,c,e,f   Turrò Garriga, Oriol ^b   Barrot De La Puente, Joan ^d,e   Franch Nadal, Josep ^d,e   Mundet Tuduri, Xavier ^e,g  

^a EAP Anglès   (Spain)

^b GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

^e INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^f Parc Hospitalari Martí i Julià   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiovascular disease; Chronic kidney disease; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; SPAIN; SYSTOLIC BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SPAIN;

EID: 84907447074     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-150     Document Type: Article

References (36)

1. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention, Circulation 2003 108 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387
2. Chronic kidney disease: effects on the cardiovascular system. Schiffrin EL, Lipman ML, Mann JF, Circulation 2007 116 85 97 10.1161/CIRCULATIONAHA.106.678342 17606856
3. Chronic kidney disease as a global public health problem: approaches and initiatives a position statement from Kidney Disease Improving Global Outcomes. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G, Kidney Int 2007 72 247 259 10.1038/sj.ki.5002343 17568785
4. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Mogensen CE, Christensen CK, Vittinghus E, Diabetes 1983 32 2 64 78 6400670
5. Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG, Chronic Kidney Disease Prognosis Consortium, Lancet 2012 380 1662 1673 10.1016/S0140-6736(12)61350-6 23013602
6. Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC, Chronic Kidney Disease Prognosis Consortium, Lancet 2012 380 1649 1661 10.1016/S0140-6736(12)61272-0 23013600
7. Extended prognostic value of urinary albumin excretion for cardiovascular events. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group, J Am Soc Nephrol 2008 19 1785 1791 10.1681/ASN.2007101065 18525003
8. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S, ONTARGET Investigators, J Am Soc Nephrol 2011 22 1353 1364 10.1681/ASN.2010091001 21719791
9. Relation between kidney function, proteinuria, and adverse outcomes. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, Alberta Kidney Disease Network, JAMA 2010 303 423 429 10.1001/jama.2010.39 20124537
10. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V, BMJ 2010 341 4986 doi: 10.1136/bmj.c4986 10.1136/bmj.c4986 20884698
11. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Lancet 2010 375 2073 2081 20483451
12. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the CasaleMonferrato study. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, Soddu A, Perotto M, Pagano G, Cavallo-Perin P, Diabetologia 2007 50 941 948 10.1007/s00125-007-0616-1 17333106
13. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH, Med J Aust 2006 185 140 144 16893353
14. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment co-existing with NIDDM [NEFRON] 11). Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC, Diabetes Care 2009 32 1497 1502 10.2337/dc08-2186 19470839
15. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J, ADVANCE Collaborative Group, J Am Soc Nephrol 2009 20 1813 1821 10.1681/ASN.2008121270 19443635
16. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J, Am J Epidemiol 2008 167 1226 1234 10.1093/aje/kwn033 18385206
17. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Yokoyama H, Oishi M, Kawai K, Sone H, Japan Diabetes Clinical Data Management Study Group, Diabet Med 2008 25 1426 1432 10.1111/j.1464-5491.2008.02592.x 19046241
18. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X, Barrot-De la Puente J, Coll de Tuero G, BMC Nephrol 2013 14 46 10.1186/1471-2369-14-46 23433046
19. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9-200905050-00006 19414839
20. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013 3 5 150
21. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort, Nephrol Dial Transplant 2008 23 3851 3858 10.1093/ndt/gfn356 18641082
22. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Satchell SC, Tooke JE, Diabetologia 2008 51 714 725 10.1007/s00125-008-0961-8 18347777
23. The relationship between proteinuria and coronary risk: A systematic review and meta-analysis. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, Jardine M, Gallagher M, Turnbull F, Chalmers J, Craig J, Huxley R, PLoS Med 2008 5 207 doi:10.1371 /journal.pmed. 0050207 10.1371/journal.pmed.0050207 18942886
24. Impact of microalbuminuria on incident stroke: a meta-analysis. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B, Stroke 2010 41 2625 2631 10.1161/STROKEAHA.110.581215 20930164
25. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. Muntner P, He J, Hamm L, Loria C, Whelton PK, J Am Soc Nephrol 2002 13 745 753 11856780
26. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ, J Am Coll Cardiol 2003 41 47 55 12570944
27. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ, J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371
28. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Garg AX, Clark WF, Haynes RB, House AA, Kidney Int 2002 61 1486 1494 10.1046/j.1523-1755.2002.00270.x 11918756
29. Chronic kidney disease and therisks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 13 1296 1305 10.1056/NEJMoa041031 15385656
30. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. Stehouwer CD, Smulders YM, J Am Soc Nephrol 2006 17 2106 2111 10.1681/ASN.2005121288 16825333
31. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. RT; PREVEND Study Group. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM, Kidney Int 2000 58 1703 1710 10.1046/j.1523-1755.2000.00331.x 11012904
32. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Coresh J, Astor B, Sarnak MJ, Curr Opin Nephrol Hypertens 2004 13 73 81 10.1097/00041552-200401000-00011 15090863
33. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Rigalleau V, Lasseur C, Raffaitin C, Beauvieux MC, Barthe N, Chauveau P, Combe C, Gin H, Diabetes Care 2007 30 2034 2039 10.2337/dc07-0140 17485574
34. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Arosio M, Trevisan R, Vedovato M, Cignarelli M, Andreozzi F, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Diabetes Care 2012 35 143 149 10.2337/dc11-1380 22124714
35. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL, KEEP Investigators, Arch Intern Med 2007 167 1122 1129 10.1001/archinte.167.11.1122 17563019
36. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, Levy D, Fox CS, Arch Intern Med 2007 167 1386 1392 10.1001/archinte.167.13.1386 17620532